Salehi R - Search Results

1

Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents.

Mirzaei H, Sahebkar A, Avan A, Jaafari MR, Salehi R, Salehi H, Baharvand H, Rezaei A, Hadjati J, Pawelek JM, Mirzaei HR. Mirzaei H, et al. Among authors: salehi r, salehi h. Curr Med Chem. 2016;23(5):455-63. doi: 10.2174/0929867323666151217122033. Curr Med Chem. 2016. PMID: 26674785 Review.

2

EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies.

Nedaeinia R, Avan A, Manian M, Salehi R, Ghayour-Mobarhan M. Nedaeinia R, et al. Among authors: salehi r. Curr Drug Targets. 2014;15(14):1293-301. doi: 10.2174/1389450115666141125123003. Curr Drug Targets. 2014. PMID: 25429712 Review.

3

Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.

Bahrambeigi V, Ahmadi N, Salehi R, Javanmard SH. Bahrambeigi V, et al. Among authors: salehi r. Immunol Invest. 2015;44(3):216-36. doi: 10.3109/08820139.2014.988719. Epub 2015 Jan 7. Immunol Invest. 2015. PMID: 25565576

4

Early detection of colorectal cancer: from conventional methods to novel biomarkers.

Vatandoost N, Ghanbari J, Mojaver M, Avan A, Ghayour-Mobarhan M, Nedaeinia R, Salehi R. Vatandoost N, et al. Among authors: salehi r. J Cancer Res Clin Oncol. 2016 Feb;142(2):341-51. doi: 10.1007/s00432-015-1928-z. Epub 2015 Feb 17. J Cancer Res Clin Oncol. 2016. PMID: 25687380 Review.

5

Phylogenetic Analysis of Selected Menthol-Producing Species Belonging to the Lamiaceae Family.

Mirzaei M, Mirzaei H, Sahebkar A, Bagherian A, Masoud Khoi MJ, Reza Mirzaei H, Salehi R, Reza Jaafari M, Kazemi Oskuee R. Mirzaei M, et al. Among authors: salehi r. Nucleosides Nucleotides Nucleic Acids. 2015;34(9):650-7. doi: 10.1080/15257770.2015.1047030. Nucleosides Nucleotides Nucleic Acids. 2015. PMID: 26252633

6

The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment.

Gholamin S, Pasdar A, Khorrami MS, Mirzaei H, Mirzaei HR, Salehi R, Ferns GA, Ghayour-Mobarhan M, Avan A. Gholamin S, et al. Among authors: salehi r. Curr Pharm Des. 2016;22(3):397-403. doi: 10.2174/1381612822666151112151924. Curr Pharm Des. 2016. PMID: 26561061 Review.

7

Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.

Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM, Ebrahimnejad H, Nahand JS, Hadjati J, Asrami MO, Fadaei S, Salehi R, Mirzaei H. Salarinia R, et al. Among authors: salehi r. Curr Cancer Drug Targets. 2016;16(9):773-788. doi: 10.2174/1568009616666151207110143. Curr Cancer Drug Targets. 2016. PMID: 26638884 Review.

8

PiggyBac as a novel vector in cancer gene therapy: current perspective.

Mirzaei H, Sahebkar A, Jaafari MR, Hadjati J, Javanmard SH, Mirzaei HR, Salehi R. Mirzaei H, et al. Among authors: salehi r. Cancer Gene Ther. 2016 Feb-Mar;23(2-3):45-7. doi: 10.1038/cgt.2015.68. Epub 2016 Jan 8. Cancer Gene Ther. 2016. PMID: 26742580

9

Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.

Nedaeinia R, Sharifi M, Avan A, Kazemi M, Rafiee L, Ghayour-Mobarhan M, Salehi R. Nedaeinia R, et al. Among authors: salehi r. Cancer Gene Ther. 2016 Aug;23(8):246-53. doi: 10.1038/cgt.2016.25. Epub 2016 Jul 1. Cancer Gene Ther. 2016. PMID: 27364574

10

SiRNA and epigenetic aberrations in ovarian cancer.

Mirzaei H, Yazdi F, Salehi R, Mirzaei HR. Mirzaei H, et al. Among authors: salehi r. J Cancer Res Ther. 2016 Apr-Jun;12(2):498-508. doi: 10.4103/0973-1482.153661. J Cancer Res Ther. 2016. PMID: 27461600 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page